Tactile Medical, a medical technology company, recently appointed Laura King to its Board of Directors and as a member of the Audit and Compliance & Reimbursement Committees. King brings with her extensive experience, having previously served as a Company Officer at General Electric Company (GE). Her appointment is expected to benefit Tactile Medical as it continues to expand its impact in providing at-home therapies for people with chronic disorders.
Tactile Medical is a leader in developing and marketing at-home therapies for chronic conditions such as lymphedema, lipedema, chronic venous insufficiency, and chronic pulmonary disease. The company collaborates with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs, and improve the quality of life for tens of thousands of patients each year.
The market has reacted to these announcements by moving the company's shares 0.3% to a price of $17.29. For more information, read the company's full 8-K submission here.
